本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ocular Therapeutix

11.33
-0.0500-0.44%
盘后11.330.00000.00%17:20 EDT
成交量:212.59万
成交额:2,416.32万
市值:18.05亿
市盈率:-9.85
高:11.57
开:11.56
低:11.23
收:11.38
数据加载中...
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/07/22

重要事件披露

8-K - Current report
2021/06/22

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report
2021/03/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans